Chapter 1. Hawthorn Extracts Market – Scope & Methodology
1.1 Market Segmentation
1.2 Scope, Assumptions & Limitations
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
Chapter 2. Hawthorn Extracts Market– Executive Summary
2.1 Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.2.1 Demand Side
2.2.2 Supply Side
2.3 Attractive Investment Propositions
2.4 COVID-19 Impact Analysis
Chapter 3. Hawthorn Extracts Market– Competition Scenario
3.1 Market Share Analysis & Company Benchmarking
3.2 Competitive Strategy & Development Scenario
3.3 Competitive Pricing Analysis
3.4 Supplier-Distributor Analysis
Chapter 4. Hawthorn Extracts Market- Entry Scenario
4.1 Regulatory Scenario
4.2 Case Studies – Key Start-ups
4.3 Customer Analysis
4.4 PESTLE Analysis
4.5 Porters Five Force Model
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Powers of Customers
4.5.3 Threat of New Entrants
4.5.4 Rivalry among Existing Players
4.5.5 Threat of Substitutes
Chapter 5. Hawthorn Extracts Market– Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities
Chapter 6. Hawthorn Extracts Market– By End Use Industry
6.1 Introduction/Key Findings
6.2 Pharmaceutical
6.3 Brewery
6.4 Y-O-Y Growth trend Analysis By End Use Industry
6.5 Absolute $ Opportunity Analysis By End Use Industry, 2023-2030
Chapter 7. Hawthorn Extracts Market– By Sales Channel
7.1 Introduction/Key Findings
7.2 Mass Merchandise
7.3 Natural & Health Food
7.4 Direct Sales
7.5 Y-O-Y Growth trend Analysis By Sales Channel
7.6 Absolute $ Opportunity Analysis By Sales Channel, 2023-2030
Chapter 8. Hawthorn Extracts Market, By Geography – Market Size, Forecast, Trends & Insights
8.1 North America
8.1.1 By Country
8.1.1.1 U.S.A.
8.1.1.2 Canada
8.1.1.3 Mexico
8.1.1.4 By End Use Industry
8.1.2 By Sales Channel
8.1.3 Countries & Segments - Market Attractiveness Analysis
8.2 Europe
8.2.1 By Country
8.2.1.1 U.K
8.2.1.2 Germany
8.2.1.3 France
8.2.1.4 Italy
8.2.1.5 Spain
8.2.1.6 Rest of Europe
8.2.2 By End Use Industry
8.2.3 By Sales Channel
8.2.4 Countries & Segments - Market Attractiveness Analysis
8.3 Asia Pacific
8.3.1 By Country
8.3.1.1 China
8.3.1.2 Japan
8.3.1.3 South Korea
8.3.1.4 India
8.3.1.5 Australia & New Zealand
8.3.1.6 Rest of Asia-Pacific
8.3.2 By End Use Industry
8.3.3 By Sales Channel
8.3.4 Countries & Segments - Market Attractiveness Analysis
8.4 South America
8.4.1 By Country
8.4.1.1 Brazil
8.4.1.2 Argentina
8.4.1.3 Colombia
8.4.1.4 Chile
8.4.1.5 Rest of South America
8.4.2 By End Use Industry
8.4.3 By Sales Channel
8.4.4 Countries & Segments - Market Attractiveness Analysis
8.5 Middle East & Africa
8.5.1 By Country
8.5.1.1 United Arab Emirates (UAE)
8.5.1.2 Saudi Arabia
8.5.1.3 Qatar
8.5.1.4 Israel
8.5.1.5 South Africa
8.5.1.6 Nigeria
8.5.1.7 Kenya
8.5.1.8 Egypt
8.5.1.9 Rest of MEA
8.5.2 By End Use Industry
8.5.3 By Sales Channel
8.5.4 Countries & Segments - Market Attractiveness Analysis
Chapter 9. Hawthorn Extracts Market– Company Profiles – (Overview, Hawthorn Extracts Market Portfolio, Financials, Strategies & Developments)
9.1 Runfuture
9.2 Co., Ltd
9.3 Xian Rainbow Biotech Co
9.4 Bolise Co
9.5 MediHerb
9.6 Xian Greena Biotech Co.
9.7 Pure Encapsulations, Inc.
9.8 The Pharmaceutical Plant Company Pty Lt
9.9 MB-Holding GmbH & Co.
9.10 Malay Ingredient Group-MIG
9.11 Xian Victory Biochemical Technology Co.
2850
5250
4500
1800
Frequently Asked Questions
The Global Hawthorn Extracts Market was valued at USD 47.5 Million and is projected to reach a market size of USD 89.23 Million by the end of 2030. Over the forecast period of 2023-2030, the market is projected to grow at a CAGR of 8.2%.
The COVID-19 pandemic has increased consumer interest in natural health products, positively affecting the Hawthorn Extracts Market.
The direct sales channel segment is witnessing the fastest growth as consumers seek convenient online purchasing options.
Key drivers include the rising demand for natural health products and the awareness of hawthorn extracts' potential cardiovascular benefits.
Challenges include fluctuating raw material costs and regulatory hurdles in different regions.